adenosine monophosphate has been researched along with Substance Withdrawal Syndrome in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Corder, G; Donahue, RR; Doolen, S; He, Y; Hu, X; Jutras, BL; McCarson, KE; Mogil, JS; Storm, DR; Taylor, BK; Wang, ZJ; Wieskopf, JS; Winter, MK | 1 |
| Leung, AW; Wu, SL; Yew, DT | 1 |
| Chen, Y; Li, F; Li, J; Liu, Y; Lu, X; Su, R; Wu, N | 1 |
| Cao, JL; Ding, HL; Duan, SM; Zeng, YM; Zhang, LC | 1 |
1 review(s) available for adenosine monophosphate and Substance Withdrawal Syndrome
| Article | Year |
|---|---|
Acupuncture for Detoxification in Treatment of Opioid Addiction.
Topics: Acupuncture Therapy; Adenosine Monophosphate; Animals; Brain-Derived Neurotrophic Factor; Dynorphins; Electroacupuncture; Humans; Opioid-Related Disorders; Substance Withdrawal Syndrome | 2016 |
3 other study(ies) available for adenosine monophosphate and Substance Withdrawal Syndrome
| Article | Year |
|---|---|
Constitutive μ-opioid receptor activity leads to long-term endogenous analgesia and dependence.
Topics: Acute Pain; Adenosine Monophosphate; Adenylyl Cyclases; Animals; Chronic Pain; Disease Models, Animal; Freund's Adjuvant; Hyperalgesia; Isoflurane; Male; Mice; Naltrexone; Nociceptive Pain; Receptors, N-Methyl-D-Aspartate; Receptors, Opioid, mu; Spinal Cord; Substance Withdrawal Syndrome | 2013 |
Imidazoline receptor antisera-selected/Nischarin regulates the effect of agmatine on the development of morphine dependence.
Topics: Adenosine Monophosphate; Adrenergic alpha-Antagonists; Agmatine; Animals; Benzofurans; Cells, Cultured; Drug Interactions; Gene Knockdown Techniques; Hippocampus; Imidazoles; Imidazoline Receptors; Immune Sera; Intracellular Signaling Peptides and Proteins; Male; Mice; Mice, Inbred BALB C; Morphine Dependence; Neurons; Proto-Oncogene Proteins c-fos; RNA, Small Interfering; Substance Withdrawal Syndrome | 2012 |
Pretreatment with midazolam suppresses morphine withdrawal response in mice and rats.
Topics: Adenosine Monophosphate; Animals; Anti-Anxiety Agents; Mice; Midazolam; Morphine Dependence; Naloxone; Oncogene Proteins v-fos; Rats; Rats, Sprague-Dawley; Spinal Cord; Substance Withdrawal Syndrome | 2002 |